Study of Exchange of Travoprost Intraocular Implant

PHASE2CompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

November 19, 2020

Primary Completion Date

February 28, 2022

Study Completion Date

February 28, 2022

Conditions
Open Angle Glaucoma
Interventions
DRUG

Travoprost

Implantation and exchange of a Travoprost Intraocular Implant through a clear corneal incision

Trial Locations (14)

34209

The Eye Associates of Manatee, Manatee

34239

Center for Sight, Sarasota

34471

Ocala Eye, Ocala

51104

Jones Eye Clinic, Sioux City

57108

Vance Thompson Vision, Sioux Falls

73112

Oklahoma Eye Surgeons, Oklahoma City

75965

Lehmann Eye Center, Nacogdoches

78746

Texan Eye, Austin

80525

Eye Center of northern Colorado, PC, Fort Collins

92545

Inland Eye Specialists, Hemet

94954

North Bath Eye Associates, Inc., Petaluma

01523

D'Ambrosio Eye Care, Lancaster

07079

Northern New Jersey Eye Institute, South Orange

Unknown

Asian Eye Institute, Makati City

Sponsors
All Listed Sponsors
lead

Glaukos Corporation

INDUSTRY

NCT04615403 - Study of Exchange of Travoprost Intraocular Implant | Biotech Hunter | Biotech Hunter